Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruklanthi de Alwis

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|June 4, 2021
Antibody sugars are bittersweetRuklanthi de Alwis, Eng Eong Ooi
Methods in Molecular Biology (Clifton, N.J.)|April 4, 2014
Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based techniqueRuklanthi de Alwis, Aravinda M de Silva
Current Treatment Options in Infectious Diseases|August 25, 2020
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow FeverAmanda Makha Bifani, Eugenia Z Ong, Ruklanthi de Alwis
Current Treatment Options in Infectious Diseases|November 11, 2020
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow FeverAmanda Makha Bifani, Eugenia Z Ong, Ruklanthi de Alwis
Pathogens (Basel, Switzerland)|May 28, 2022
Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput SerologyCharles Kevin Tiu, Feng Zhu, Lin-Fa Wang, et al.
Ebiomedicine|April 29, 2020
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine developmentRuklanthi de Alwis, Shiwei Chen, Esther S Gan, et al.
Journal of Virology|August 8, 2014
Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clonesScott A Smith, A Ruklanthi de Alwis, Nurgun Kose, et al.
The Journal of Infectious Diseases|March 26, 2013
Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristicsScott A Smith, Ruklanthi de Alwis, Nurgun Kose, et al.
Plos Pathogens|March 25, 2010
Natural strain variation and antibody neutralization of dengue serotype 3 virusesWahala M P B Wahala, Eric F Donaldson, Ruklanthi de Alwis, et al.
JCI Insight|September 28, 2021
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccineRoland Tschismarov, Raphaël M Zellweger, Min Jie Koh, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|June 4, 2021
Antibody sugars are bittersweetRuklanthi de Alwis, Eng Eong Ooi
Methods in Molecular Biology (Clifton, N.J.)|April 4, 2014
Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based techniqueRuklanthi de Alwis, Aravinda M de Silva
Current Treatment Options in Infectious Diseases|August 25, 2020
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow FeverAmanda Makha Bifani, Eugenia Z Ong, Ruklanthi de Alwis
Current Treatment Options in Infectious Diseases|November 11, 2020
Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow FeverAmanda Makha Bifani, Eugenia Z Ong, Ruklanthi de Alwis
Pathogens (Basel, Switzerland)|May 28, 2022
Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput SerologyCharles Kevin Tiu, Feng Zhu, Lin-Fa Wang, et al.
Ebiomedicine|April 29, 2020
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine developmentRuklanthi de Alwis, Shiwei Chen, Esther S Gan, et al.
Journal of Virology|August 8, 2014
Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clonesScott A Smith, A Ruklanthi de Alwis, Nurgun Kose, et al.
The Journal of Infectious Diseases|March 26, 2013
Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristicsScott A Smith, Ruklanthi de Alwis, Nurgun Kose, et al.
Plos Pathogens|March 25, 2010
Natural strain variation and antibody neutralization of dengue serotype 3 virusesWahala M P B Wahala, Eric F Donaldson, Ruklanthi de Alwis, et al.
JCI Insight|September 28, 2021
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccineRoland Tschismarov, Raphaël M Zellweger, Min Jie Koh, et al.
Pageof 5